semaglutide approval for mash India has approved Wegovy (semaglutide 2.4 mg) treating (metabolic dysfunction-associated steatohepatitis)—a serious form of fatty liver disease that can silently progress to liver damage if left untreated. MASH develops when Wegovy Is Now the Second

This once-daily tablet serves as a viable option for medical weight loss patients looking to avoid injections

Certain foods trigger worse GI symptoms on semaglutide, particularly high-fat meals, greasy foods, and large portions of anything

For women of reproductive age, understanding the interaction between tirzepatide and reproductive health becomes even more important when drug levels exceed tested ranges

Tong (Purdue University) for imaging assistance

You may feel more affected by alcohol if you are eating less than usual, drinking on an empty stomach, losing weight, dehydrated, drinking less often than before, or taking other medications that interact with alcohol

Within a few weeks, patients can begin to see results, with the best outcomes often occurring after several months